Flu anti-virus causes 17% profit jump October 20, 2005 Roche, the maker of bird flu anti-viral Tamiflu, yesterday announced a third quarter revenue increase of 17 per cent thanks to a jump in sales of the drug. The Swiss firm said sales of Tamiflu had more than doubled to SFr279m (£123m) and the companies overall sales for the quarter ending September climbed to SFr8.8bn. [...]